Quality of care: from theory to practice Kim A Eagle MD Albion Walter Hewlett Professor of Internal Medicine Chief, Clinical Cardiology Co-Director, Heart.

Slides:



Advertisements
Similar presentations
Associations Between Outpatient Heart Failure Process of Care Measures and Mortality Gregg C. Fonarow, Nancy M. Albert, Anne B. Curtis, Mihai Gheorghiade,
Advertisements

Connie N. Hess, MD, Bimal R. Shah, MD, MBA, S. Andrew Peng, MS, Laine Thomas, PhD, Matthew T. Roe, MD, MHS, Eric D. Peterson, MD, MPH Relationship of Early.
V.: 9/7/2007 AC Submit1 Statistical Review of the Observational Studies of Aprotinin Safety Part I: Methods, Mangano and Karkouti Studies CRDAC and DSaRM.
Does Preoperative Hemoglobin Value Predict Postoperative Cardiovascular Complications after Total Joint Arthroplasty? Kishor Gandhi MD, MPH, Eugene Viscusi.
KAREN L. WALKER MS JONATHAN J. SHUSTER PHD THOMAS M. BEAVER MD, MPH DIVISION OF THORACIC AND CARDIOVASCULAR SURGERY DIVISION OF BIOSTATISTICS UNIVERSITY.
The Influence of Radial vs. Femoral Access on Acute Blood Loss in Patients Undergoing Percutaneous Coronary Intervention Amit Nanda 1, Amit P. Amin 2,
Comparison of the New Mayo Clinic Risk Scores and Clinical SYNTAX Score in Predicting Adverse Cardiovascular Outcomes following Percutaneous Coronary Intervention.
The Relationship Between CMS Quality Indicators and Long-term Outcomes Among Hospitalized Heart Failure Patients Mark Patterson, Ph.D., M.P.H. Post-doctoral.
Relationship of Time to Treatment and Door-to-Balloon Time to Mortality in Patients with Acute Myocardial Infarction Treated with Primary Angioplasty Christopher.
The Radial Approach to Percutaneous Coronary Intervention Is Associated With a Lower Risk for Complications Regardless of Radial Procedure Volume: A Report.
CPORT- E Trial Randomized trial comparing medical, economic and quality of life outcomes of non-primary PCI at hospitals with and without on-site cardiac.
Clinical Pharmacist Intervention in Cardiac Patients With Renal Impairment Elham Al-Shammari, B.Sc. Pharm. Hisham Abou-Auda, Ph. D. Meshal Al-Mutairi,
Can we prevent myocardial and renal revascularization injury? Preventive effect of trimetazidine MR on myocardial and renal injury in diabetic patients.
“Hospital Performance Recognition with the Get with the Guidelines Program and Mortality for Acute Myocardial Infarction and Heart Failure Paul A Heidenreich,
ACHD Patients Should Receive Treatment in Adult Institutions Society of Thoracic Surgeons Adult Cardiac Surgery Database reports 39,872 adults undergoing.
Open Repair of Ruptured Descending Thoracic and Thoracoabdominal Aortic Aneurysms in 100 Consecutive Cases Mario F. Gaudino, Christopher Lau, Monica Munjal,
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Quality of care, part 3: bypass surgery Kim A Eagle MD Albion Walter Hewlett Professor of Internal Medicine Chief, Clinical Cardiology Co-Director, Heart.
Validation of Mayo Clinic Risk Adjustment Model for In-Hospital Mortality following Percutaneous Coronary Interventions using the National Cardiovascular.
New guidelines for CABG
Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
Patterns of red blood cell transfusion use and outcomes in patients undergoing percutaneous coronary intervention in contemporary clinical practice: Insights.
The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries Dr. Christian Finley MD MPH FRCSC McMaster University.
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Ten-Year Follow-up Survival of the Medicine, Angioplasty, or Surgery Study (MASS-II): a Randomized Controlled Clinical Trial of Therapeutic Strategies.
Female Gender Is An Independent Predictor Of In-Hospital Mortality After STEMI In The Era of Primary PCI. Insights From The Greater Paris Area PCI Registry.
Does Openness Improve Outcome ? The North-West Quality Improvement Program Dr R H Stables Cardiothoracic Centre Liverpool.
Athens Cardiology Update CADILLAC Study Blood Transfusion after Myocardial Infarction: Friend, Foe or double-edged Sword? Georgios I. Papaioannou,
Revascularizaton of Ischemic DCM Percutaneous Revascularization and Hemodynamic Support Matthew R. Wolff, M.D. University of Wisconsin Disclosures: Cordis.
Quality of care, part 4: MI Kim A Eagle MD Albion Walter Hewlett Professor of Internal Medicine Chief, Clinical Cardiology Co-Director, Heart Care Program.
Decreasing Incidence of Cardiogenic Shock Summary and Comment by J. Stephen Bohan, MD, MS, FACP, FACEP Published in Journal Watch Emergency Medicine December.
Relationship between total cholesterol and 90-day mortality after acute myocardial infarction in patients not on statins Rishi Parmar 2 nd year Medicine.
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
Acute Heart Failure in Apical Ballooning Syndrome (Takotsubo/Stress Cardiomyopathy) Clinical Correlates and Mayo Clinic Risk Score Malini Madhavan, MBBS;
Bleeding in Patients Undergoing Percutaneous Coronary Interventions: A Risk Model From 302,152 Patients in the NCDR. Sameer K. Mehta MD, Andrew D. Frutkin.
Treatment and Risk in Heart Failure: Gaps in Evidence or Quality? Pamela N. Peterson, MD MSPH; John S. Rumsfeld, MD PhD; Li Liang PhD; Adrian F. Hernandez,
Acute Myocardial Infarction (Heart Attack) Committee Membership: B. Majcher, APRN, C. Mulhall, APRN, K. McLean, MD, M. Jarotkiewicz MBA, M. Morrow, RN,
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Presenter Disclosure Information DISCLOSURE INFORMATION: The following relationships exist related to this presentation Stock options None; Consults for.
The Impact of For-Profit Hospital Status on the Care and Outcomes of Patients with NSTEMI: Results From CRUSADE Bimal R. Shah, MD, Seth W. Glickman, MD,
Clinical Trial Results. org Characteristics, Management, and Outcomes of 5,557 Patients Age ≥90 Years With Acute Coronary Syndromes: Results From the CRUSADE.
The Impact of For-Profit Hospital Status on the Care and Outcomes of Patients with NSTEMI: Results From CRUSADE Bimal R. Shah, MD, Seth W. Glickman, MD,
Managing AMI – much work still to do? MONDAY, 28 th FEBRUARY – SESSION 3 Patrick Goldstein EXPERTS WORKSHOP ON EARLY TREATMENT STRATEGIES FOR ACUTE MYOCARDIAL.
Late Open Artery Hypothesis Jason S. Finkelstein, M.D. Tulane University Medical Center 2/24/03.
Allen Jeremias, Neal Kleiman, Deborah Nassif, Wen-Hua Hsieh, Michael Pencina, Kelly Maresh, Manish Parikh, Donald Cutlip, Ron Waksman, Steven Goldberg,
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Acute Myocardial Infarction Committee Membership : K. McLean, MD, M. Jarotkiewicz MBA, Administrative Director Cardiovascular Service Line, Mary Morrow,
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Survival of patients with diabetes and multivessel.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship Between Operator Volume and Adverse.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Smoking Is Associated With Adverse Clinical Outcomes.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Coronary Intervention Complications.
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Nuisance Bleeding With Prolonged Dual Antiplatelet.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
PCI related in-hospital mortality based on race and gender in the USA
Successful CTO PCI Associated with Lower Mortality Risk
Evaluating Policies in Cardiovascular Medicine
Complication Rates for Percutaneous Coronary Intervention in South Australia Aashray Gupta1, Rosanna Tavella1,2, Margaret Arstall1,3, Matthew Worthley1,2,
Clopidogrel Reduces ADP-Induced Expression of Platelet-derived CD40L
Fewer PCIs After Public Reporting Changes in NY
Giuseppe Biondi Zoccai, MD
Significance of Periprocedural Myocardial Infarctions in Percutaneous Coronary Interventions A New Look at an Old Topic Abhiram Prasad, MD, FRCP, FESC,
Global Registry of Acute Coronary Events: GRACE
Risk Stratification and Interventional Cardiology: Robert L
No Financial Disclosure or Conflict of Interest
Maintenance of Long-Term Clinical Benefit with
Atlantic Cardiovascular Patient Outcomes Research Team
Presentation transcript:

Quality of care: from theory to practice Kim A Eagle MD Albion Walter Hewlett Professor of Internal Medicine Chief, Clinical Cardiology Co-Director, Heart Care Program University of Michigan Ann Arbor, MI Mauro Moscucci MD Assistant Professor of Medicine Director, Interventional Cardiology Program University of Michigan Ann Arbor, MI

Factors that effect in-hospital mortality have been well defined. Risk of mortality can now be assessed on the basis of comorbid conditions. Standards for appropriate modeling, risk adjustment, and evaluation for percutaneous coronary intervention (PCI) have not been well developed In-hospital mortality PCI outcomes

Risk adjustment models Risk adjustment models have proven very effective in accounting for mortality rate  the northern New England risk adjustment model for in-hospital mortality  the Cleveland Clinic model Predictors of in-hospital mortality

New England model A prospective cohort study of in-hospital mortality after PCI in northern New England was conducted from 1994 to Data from 52 interventional cardiologists on consecutive hospital admissions for PCI were collected (98.5% of all patients who underwent a PCI during the study period). The data were used to develop and internally validate a multivariate prediction equation for in- hospital mortality that required only routinely collected data known before the PCI. O’Connor, et al. J Am Coll Cardiol 1999;34: PCI and in-hospital mortality

New England model  older age  congestive heart failure  peripheral or cerebrovascular disease  increased creatinine levels  lowered ejection fraction  cardiogenic shock  acute myocardial infarction  urgent priority  emergent priority  preprocedure insertion of an intra-aortic balloon pump  PCI of a type C lesion O’Connor, et al. J Am Coll Cardiol 1999;34: Univariate assessment Variables associated with an increased risk of in-hospital mortality

New England model Variables included  age  indication for intra-aortic balloon pump (IABP)  procedural priority for IABP  and preprocedure use of an IABP  congestive heart failure  peripheral or cerebrovascular disease  elevated creatinine level  EF  intervention on a type C lesion O’Connor, et al. J Am Coll Cardiol 1999;34: Multivariate prediction equation Variables not included  sex  history of MI  use of preprocedure intravenous nitroglycerin  LVEDP  number of diseased coronary arteries  intervention on a proximal left anterior descending coronary artery

Cleveland Clinic model Data from consecutively treated patients were taken from quality-controlled databases at 5 high-volume centers. Multivariable logistic regression models were used to examine individual and interaction relations between baseline characteristics of patients and death and also the composite of death, Q-wave infarction, or bypass surgery. These models were used for risk adjustment, and the relations between both yearly caseload and years of interventional experience and the 2 adverse outcome measures were explored for all 38 physicians who performed at least 30 procedures per year. Ellis SG, et al Circulation 1997;95: Model predictive of death after PCI

Cleveland Clinic model Risk-adjusted measures of both death and the composite adverse outcome were inversely related to the number of procedures each operator performed annually, but were not related to years of experience. High-volume operators had a lower incidence of major complications than did lower-volume operators, but the difference was not consistent for all operators. Both adverse outcomes were more closely related to the logarithm of caseload (for death, r=.37, p=0.01; for death, Q-wave infarction, or bypass surgery, r=.58, p<0.001) than to linear caseload. Results Ellis SG, et al Circulation 1997;95:

Mathematical models Mathematical formulas are used to calculate the expected mortality rate of an institution. The formulas make adjustments for patient population and compare expected and observed mortality rates. The expected mortality rate of an institution serving a high-risk population is not necessarily higher than that for an institution serving a low- risk population. Expected mortality rates

University of Michigan Every operator receives cardiac reports that include observed and expected mortality rates and the baseline comorbidities of his or her patients. A multicenter registry is used to provide the same type of feedback to operators from 6 other hospitals in Michigan. Operator feedback

Mathematical models Modern mathematical science gives physicians outcome data that is mathematically robust in terms of risk assessment. Because the mathematical model provides an accurate estimate of patient risk, risk- adjusted data can be used to help patients understand the risks of certain procedures. Statistical confidence

Mathematical models The mathematical models may identify situations in which the expected risk of death may be so high as to render care futile. In such situations, a realistic estimate of the likelihood of death can be provided to the patient, so the patient will not have unwarranted expectations. Predicting death

Mathematical models A model has been developed to assess the risk of mortality in acute renal failure patients in ICU requiring dialysis. Significant factors  male gender  respiratory failure requiring intubation  hematologic dysfunction  bilirubin < 2.0 mg/dL  the absence of surgery  serum creatinine on the first dialysis treatment day  an increasing number of failed organ systems  an increased BUN from the time of admission Application to other conditions Paganini EP, et al. Clin Nephrol 1996;46(3):

A controversy Several studies have shown that there appears to be a relation between operator volume and outcome. However, with new technology (particularly coronary stent) even low-volume operators can still have a good outcome. Operator volume and outcome

ACC recommendations Statistical data support the premise that a physician who performs coronary interventional procedures infrequently is unlikely to be as proficient as one who performs them often. The low-volume operator has fewer opportunities to maintain skills, and is less able to acquire the additional skills needed to become proficient in the use of new techniques and devices. The low-volume operator is likely to be less experienced at recognizing and managing procedural complications. Statistical data demonstrate that operators who perform <75 procedures annually have the highest complication rates; this trend is most pronounced in institutions with an annual procedural volume <600. Hirshfeld JW, et al. J Am Coll Cardiol 1998; 31(3): Coronary interventional procedures

Volume and outcome Evidence suggests that quality might be acceptable for operators who perform fewer than 75 procedures annually but who do them in a high-volume center. There is substantial evidence suggesting that the introduction of new technology such as coronary stent has led to a significant improvement in acute outcome. Quality of procedures

Understanding process Analyzing practice variations among operators and among institutions is very beneficial. Benchmarking and comparisons identify differences among operators and institutions. Once areas needing improvement are identified, processes can be studied to determine why discrepancies exist and changes can be implemented. Benchmarking

University of Michigan A team visits other sites to evaluate and compare processes. Problem areas and important differences have been identified using this strategy. Team cohesion is fostered that is reflected in in-hospital work. Team members  a physician  a cath lab technician  a cath lab nurse  a nurse manager Benchmarking among cath labs

University of Michigan The common goals of the team make implementing changes easier. Knowing that a particular process is working elsewhere makes workers less resistant to change. Implementing changes

University of Michigan Cost procedure analysis  higher use of coronary stents  higher use of GP IIb/IIIa receptor blockers (abciximab)  much higher use of expensive devices Total lower procedure cost  decreases in vascular complications  decreases in number of transfusions  decreases in number of emergency bypasses  decreases in length of stay  fewer emergency cath lab procedures  potential for less restenosis and fewer repeat procedures Justifying new technology

University of Michigan Collaborative effort with department of clinical affairs. Annual cost data are available on all procedures performed (direct and indirect costs). Cost data are linked to outcome database. Reliable cost data

University of Michigan Interventional cardiology program will have access to clinical, financial, and patient data. Areas where costs are the result of practice variation, not actual procedures, can be identified. Costs can be closely monitored and areas can be identified where costs can be reduced. New database in development

Assessing appropriateness If a procedure is not appropriate, the care provided is not good care. Some payers that are beginning to assess appropriateness in a clinical fashion. In Michigan, Blue Cross is assessing the appropriateness of procedures performed in the past 2 years by applying criteria based on national guidelines. Indicator of procedure performance

Assessing quality Having a data base is not the final answer  a good system to collect data is required  data must be assessed in a clinical fashion  problem areas identified must be addressed By examining, benchmarking and steadily improving, change is possible. High-cost / high-risk procedures